Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 23, Issue 6, Pages 802-809
Publisher
SAGE Publications
Online
2016-08-09
DOI
10.1177/1352458516664210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responses
- (2016) Sara J. Ireland et al. JOURNAL OF NEUROIMMUNOLOGY
- B Cell Antigen Presentation Is Sufficient To Drive Neuroinflammation in an Animal Model of Multiple Sclerosis
- (2015) Chelsea R. Parker Harp et al. JOURNAL OF IMMUNOLOGY
- The pathogenic role of the inflammasome in neurodegenerative diseases
- (2015) Leslie C. Freeman et al. JOURNAL OF NEUROCHEMISTRY
- The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene Function
- (2015) Judith Field et al. PLoS One
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- The Ins and Outs of B Cells in Multiple Sclerosis
- (2015) Kevin Blauth et al. Frontiers in Immunology
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients
- (2013) Samantha Jilek et al. Multiple Sclerosis Journal
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis
- (2012) S. Jilek et al. JOURNAL OF IMMUNOLOGY
- B cells and antibodies in multiple sclerosis pathogenesis and therapy
- (2012) Markus Krumbholz et al. Nature Reviews Neurology
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
- (2011) U.-C. Meier et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting Toll-like receptors: Emerging therapeutics for multiple sclerosis management
- (2011) M. Gambuzza et al. JOURNAL OF NEUROIMMUNOLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- The role of antigen presenting cells in multiple sclerosis
- (2010) Emily M.L. Chastain et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Orchestrating innate immune responses in multiple sclerosis: Molecular players
- (2010) Marta Fernández et al. JOURNAL OF NEUROIMMUNOLOGY
- Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study
- (2010) Samantha Jilek et al. LANCET NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Intrathecal immune responses to EBV in early MS
- (2009) Emilie Jaquiéry et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
- (2008) Samantha Jilek et al. BRAIN
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started